Amalgamated Bank’s Mead Johnson Nutrition Company MJN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-13,456
Closed -$1.2M 1613
2017
Q1
$1.2M Sell
13,456
-1,704
-11% -$140K 0.06% 350
2016
Q4
$1.07M Buy
15,160
+3,539
+30% +$264K 0.05% 442
2016
Q3
$918K Buy
11,621
+19
+0.2% +$1.62K 0.05% 418
2016
Q2
$1.03M Buy
11,602
+4,161
+56% +$352K 0.06% 354
2016
Q1
$632K Buy
7,441
+1,346
+22% +$100K 0.06% 404
2015
Q4
$481K Sell
6,095
-1,597
-21% -$126K 0.06% 466
2015
Q3
$542K Buy
7,692
+285
+4% +$23.4K 0.06% 456
2015
Q2
$668K Buy
7,407
+347
+5% +$33.5K 0.07% 379
2015
Q1
$710K Buy
7,060
+1,635
+30% +$165K 0.09% 288
2014
Q4
$545K Sell
5,425
-790
-13% -$78.7K 0.09% 312
2014
Q3
$598K Buy
6,215
+382
+7% +$36.2K 0.09% 270
2014
Q2
$543K Buy
5,833
+665
+13% +$58.1K 0.08% 303
2014
Q1
$430K Sell
5,168
-104
-2% -$8.43K 0.07% 383
2013
Q4
$442K Buy
+5,272
New +$429K 0.08% 364

Other funds holding MJN

Amalgamated Bank's MJN Position: Q2 2017 in Review

Amalgamated Bank sold out of Mead Johnson Nutrition Company (MJN) in Q2 2017, closing a stake of 13,456 shares — an estimated $1.2M sold.

Amalgamated Bank first reported a position in MJN in Q4 2013 and held it in 14 quarters. The position peaked at $1.2M in Q1 2017. 7 funds tracked by Wall St. Rank hold MJN as of Q2 2017.

  • Amalgamated Bank reported no remaining Mead Johnson Nutrition Company position as of Q2 2017 after selling out during the quarter.
  • Amalgamated Bank sold 13,456 Mead Johnson Nutrition Company shares in Q2 2017, an estimated $1.2M.
  • Amalgamated Bank first reported a position in Mead Johnson Nutrition Company in Q4 2013 and held it in 14 quarters.
  • Amalgamated Bank's Mead Johnson Nutrition Company position peaked at $1.2M in Q1 2017.
  • 7 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2017.

Based on Amalgamated Bank's 13F filing for Q2 2017, filed 11 Aug 2017.